CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 49 enrolled
Drug / intervention
Talent Endoluminal Spring Graft Systemdevice
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT00695253
NCT00695253N/ACompleted
CompareCT.gov

Physician-Sponsored IDE for Talent Endoluminal Spring Graft System in Patients With AAA

Rodney A. White, M.D.·interventional·Posted Jun 11, 2008·Updated Feb 15, 2023

In Brief

A clinical study evaluating Talent Endoluminal Spring Graft System for Abdominal Aortic Aneurysms. Completed, enrolled 49 participants across 1 site.

Detailed Summary

The purpose of this study is to evaluate the safety and effectiveness of the Talent Endoluminal Spring Graft System, an investigational device, to treat abdominal aortic aneurysms (AAA). The treatment population will include patients with an abdominal aortic aneurysm who meet the inclusion/exclusion criteria. All patients in the treatment population will undergo post-procedure follow-up evaluations at one (1), six (6), and 12 months and annually thereafter up to five (5) years post-procedure.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsAbdominal Aortic Aneurysms
CountriesUnited States
Collaborators--

Timeline

N/ACompletedFinished
20022003200420052006200720082009201020112012201320142015201620172018201920202021202220232024202520262027
First PostedJun 11, 2008
Enrollment StartApr 1, 2002
Primary CompletionMar 1, 2013
TodayJul 2, 2026
Enrollment to primary: 10.9 yearsPosted 18.1 years ago

Interventions

Talent Endoluminal Spring Graft Systemdevice

Endovascular repair for patients with AAA who meet the inclusion criteria for the study